Fentanyl Citrate 63323-0810-20
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 15, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA212086
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fentanyl Citrate | 100 ug/2mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
63323-0810-20Selected20 SYRINGE in 1 CARTON (63323-810-20) / 2 mL in 1 SYRINGE (63323-810-00)